PhRMA Will Pursue Future ‘Cures’ Without Castellani: CEO Retiring Jan. 1
This article was originally published in The Pink Sheet Daily
Executive Summary
John Castellani will step down at the end of the year as president and CEO of PhRMA after leading the association since September 2010.
You may also be interested in...
AAM CEO Leonard Departs After Two Years, Creating Another Trade Group Searching For New Leader
David Gaugh, AAM’s executive VP of sciences and regulatory affairs, was named the interim CEO, making him the fourth person to run the association since February 2020.
BIO Stalwart Greenwood Announces Departure
Long-time CEO of the Biotechnology Innovation Organization will remain until after the 2020 election and help with the leadership transition.
PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.